Identification and Validation of an Immune and Ferroptosis-Combined Index for Non–Small Cell Lung Cancer
Background: Non–small cell lung cancer (NSCLC) is among the major health problems around the world. Reliable biomarkers for NSCLC are still needed in clinical practice. We aimed to develop a novel ferroptosis- and immune-based index for NSCLC.Methods: The training and testing datasets were obtained...
Enregistré dans:
Auteurs principaux: | Yang Teng, Bo Wang, Desi Shang, Ning Yang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d13b02dce62e49b196a898db2e538981 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Prognostic Implications and Immune Infiltration Analysis of ALDOA in Lung Adenocarcinoma
par: Guojun Lu, et autres
Publié: (2021) -
Four long noncoding RNAs act as biomarkers in lung adenocarcinoma
par: Zhang Zhihui, et autres
Publié: (2021) -
Potential Prognostic Biomarkers of NIMA (Never in Mitosis, Gene A)-Related Kinase (NEK) Family Members in Breast Cancer
par: Gangga Anuraga, et autres
Publié: (2021) -
Identification of circRNA_001846 as putative non–small cell lung cancer biomarker
par: Fan Yang, et autres
Publié: (2021) -
Identification of Immune-Related Key Genes in Ovarian Cancer Based on WGCNA
par: Qingli Quan, et autres
Publié: (2021)